J Korean Soc Ther Radiol.  1988 Dec;6(2):235-246.

The Role of Radiotherapy in Management of Rectal Cancer

Affiliations
  • 1Department of Radiation Ocology, Yonsei University, College of Medicine, Seoul, Korea.

Abstract

A total of 93 patients with rectal cancer treated with radiotherapy at department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center between January 1974 and December 1983 are retrospectively analysed. The patients are divided into three groups as follows: I. Postoperative radiotherapy, II. Pstoperative recurrent, III. Unresectable or Inoperable group. In postoperative radiotherapy group, overall 5 year survival rate is 34.8% and prognostic factors are presence of obstruction and degree of differentiation. In postoperative recurrent group, overall 5 year survival rate is 34.8% and prognostic factors are presence of obstruction and degree of differentiation. In postoperative recurrent group, overall 2 year survival rate is 7.4% with median survival of 13 months and prognostic factors are RT responsiveness and sex, and the local failure rate is 22.7%. In unresectable or inoperable group, overall 2 year survival rate is 19.8% with median survival of 12.6 months and prognostic factors are RT responsiveness and RT dose. The complications for RT are not significant and are acceptable in all patients.

Keyword

Radiotherapy; Rectal cancer

MeSH Terms

Humans
Radiation Oncology
Radiotherapy*
Rectal Neoplasms*
Retrospective Studies
Survival Rate
Full Text Links
  • JKSTR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr